Clinical Trial Update: Dose-confirmation Study of ASLAN001 Combined With Weekly Paclitaxel and Carboplatin in Advanced Solid Tumours, Followed by a Study in Patients With Stage I-III HER2 Positive Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

Dose-confirmation study of ASLAN001 with weekly paclitaxel and carboplatin in advanced solid tumors, followed by a Phase 1/Phase 2 study in Stage I-III HER2-pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• ASLAN001
• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: National University Hospital, Singapore | Conditions: Breast Cancer | Phase 1, Phase 2 | Status: UNKNOWN